Phantom Metatarsal Shortening
Payments companies reported to CMS as associated with Phantom Metatarsal Shortening. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Phantom Metatarsal Shortening, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Phantom Metatarsal Shortening
These are the largest totals companies reported as associated with Phantom Metatarsal Shortening. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| April Borchardt | Green Bay, WI | Podiatrist | $289.09 |
| Kevin Yee | Edison, NJ | Foot & Ankle Surgery | $257.72 |
| Maryellen Brucato | Oradell, NJ | Foot & Ankle Surgery | $189.34 |
| Avik Mukherjee | Toms River, NJ | Foot & Ankle Surgery | $189.34 |
| Darren Cowl | Mankato, MN | Foot & Ankle Surgery | $157.67 |
| James Torhorst | Waupaca, WI | Foot & Ankle Surgery | $144.82 |
| Brandon Scharer | Green Bay, WI | Podiatrist | $144.82 |
| Scott Torness | Watertown, SD | Foot & Ankle Surgery | $144.27 |
| Kevin Blue | Parker, CO | Podiatrist | $141.92 |
| Andrew Belis | Fort Myers, FL | Foot & Ankle Surgery | $136.33 |
Prescribed Phantom Metatarsal Shortening?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.